Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension
Open Access
- 1 July 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 50 (1), 167-171
- https://doi.org/10.1161/hypertensionaha.107.088799
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Carotid Intima-Media Thickness and Antihypertensive TreatmentStroke, 2006
- Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical OutcomesCirculation, 2006
- Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic StiffnessCirculation, 2005
- C-Reactive Protein Elevation Predicts Pulse Pressure Reduction in Hypertensive SubjectsHypertension, 2005
- Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery?Journal Of Hypertension, 2005
- Residual coronary risk in men aged 50–59 years treated for hypertension and hyperlipidaemia in the populationJournal Of Hypertension, 2004
- Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenololJournal of the American College of Cardiology, 2004
- Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular DiseasesCirculation, 2003
- Clinical applications of arterial stiffness; definitions and reference valuesAmerican Journal of Hypertension, 2002
- Structure and function of resistance arteries of hypertensive patients treated with a p-blocker or a calcium channel antagonistJournal Of Hypertension, 1996